Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide effect on arterial blood pressure in hypertensive patients with type 2 diabetes mellitus
2013-002348-99Phase 3Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Jul 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and hypertension (HTN) comparing Liraglutide (Victoza) with Placebo (2 arms). Primary endpoint: Change in mean 24-hour systolic blood pressure. Started Jul 2014; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)
Beyond the preview
Go deeper on 2013-002348-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002348-99.